Community Corner
Former SEC Commissioner Launches Foundation to Battle Prostate Cancer
Former Southeastern Conference commissioner Mike Slive is launching a new non-profit organization to battle prostate cancer this month.

BIRMINGHAM, AL - Former Southeaster Conference commissioner Mike Slive and Birmingham attorney Ed Meyerson are launching a new non-profit organization this month. The Mike Slive Foundation for Prostate Cancer Research, was founded by Meterson after being inspired by watching his father Battle the disease. Slive was asked to come in on the project because he, too, has battled prostate cancer.
“I reached out to Mike because I knew that together we could make a contribution to help end prostate cancer. Mike’s story is an inspiration to us all,” Meyerson said. “What our doctors do here in Alabama has a global impact on ending prostate cancer for good. More funding is crucial to make the important advancements and discoveries that will save even more lives, and The Foundation was created to ensure the needed funding is secured.”
Slive is dedicated to fighting prostate cancer – he has battled the disease several times and is a survivor. (For more updates on this story and free news alerts for your neighborhood, sign up for your local Birmingham Patch morning newsletter.)
Find out what's happening in Birminghamfor free with the latest updates from Patch.
“My life was saved by cutting-edge prostate cancer research. Now, I have the opportunity to give back and help save other lives through The Foundation,” Slive said. “No one should die from prostate cancer.”
Members of The Foundation and emcee Paul Finebaum will launch Allies in the Fight on Thursday, September 14th at the Alys Stephens Center. Presenting sponsors include Regions Bank and Medical Properties Trust.
Find out what's happening in Birminghamfor free with the latest updates from Patch.
(Photo of Mike Slive courtesy of the Southeastern Conference)
Get more local news delivered straight to your inbox. Sign up for free Patch newsletters and alerts.